Similar studies have indicated that the symptoms of UC, colon length, and tissue damage in DSS-induced colitis mice were significantly improved through the combined intervention of the FFAR1 agonist GW9508 and the FFAR4 agonist GSK137647 (106). The gene discussed is FFAR4; the disease is colitis.